Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP · NASDAQ Global Market
+$0.02 today
Vol 0.34M · Avg 0.33M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+243.20%
Period High
$39.93
Period Low
$10.88
Latest
$37.34
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
AnaptysBio, Inc.
NASDAQ:ANAB
$2.39B
Kodiak Sciences Inc.
NASDAQ:KOD
$1.87B
Septerna, Inc.
NASDAQ:SEPN
$1.58B
UroGen Pharma Ltd.
NASDAQ:URGN
$1.58B
Mind Medicine (MindMed) Inc.
MNMD
$1.56B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$1.49B
Xencor, Inc.
NASDAQ:XNCR
$928.62M
Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
$849.80M
Oculis Holding AG
NASDAQ:OCS
$630.58M
BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOT
$608.41M
What is the latest RAPP filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does RAPP have?
Intrinsic Alpha currently shows 20 recent filings for RAPP.
Explore More
Continue the stock analysis
Jump to another research area for this company.